Professor
Washington University
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
I have a broad background in basic, translational and clinical science in infectious disease. My research interests have centered around the pathogenesis of infectious disease, with a particular emphasis on the role of the microbiome and virome in infections, especially HIV and emerging viral infections such as COVID-19. Since 2006, I have been conducting clinical trials at the Washington University Infectious Disease Clinical Research Unit (ID CRU), where I currently serve as the medical director of the research unit, and PI of the AIDS Clinical Trials Group Clinical Research Site. We have utilized the expertise of the ID CRU to conduct groundbreaking clinical research in HIV through both the ACTG as well as independently funded research and have responded aggressively to the COVID-19 pandemic, conducting both translational research to understand immune responses after infection or vaccination as well as treatment, prevention and vaccination trials in participants infected with or at risk of infection with SARS-CoV-2.
